Larvol Delta - Clearmind-Medicine-Announces-First-US-Site-for-its-Phase-IIIa-Clinical-Trial-Evaluating-CMND100-in-Patients-with-Alcohol-Use-Disorder

5-methoxy-2-aminoindane (CMND-100) - Clearmind Medicine

https://www.globenewswire.com/news-release/2023/05/22/2673361/0/en/Clearmind-Medicine-Announces-First-US-Site-for-its-Phase-I-IIa-Clinical-Trial-Evaluating-CMND-100-in-Patients-with-Alcohol-Use-Disorder.html

May 22, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next